0 Commentaires
0 Parts
204 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Forums
-
Connectez-vous pour aimer, partager et commenter!
-
Generic Drug Market Scope: Growth, Share, Value, Size, and Trends"Detailed Analysis of Executive Summary Generic Drug Market Size and Share Data Bridge Market Research analyses that the generic drug market, which is USD 622.02 million in 2022, is expected to reach USD 1,323.68 million by 2030, at a CAGR of 9.9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation,...0 Commentaires 0 Parts 499 Vue 0 Aperçu
-
Generic Drug Market: Expanding Access, Affordability, and Healthcare SustainabilityMarket Overview The Global Generic Drug Market has emerged as a cornerstone of modern healthcare systems, playing a critical role in improving access to essential medicines while reducing overall treatment costs. Generic drugs are pharmaceutical products that contain the same active ingredients, dosage forms, strength, and intended use as branded drugs, offering comparable therapeutic...0 Commentaires 0 Parts 297 Vue 0 Aperçu
-
Europe Deodorant Market Scope: Growth, Share, Value, Size, and TrendsIntroduction The Europe deodorant market represents a mature yet continuously evolving segment of the broader personal care and cosmetics industry. Deodorants have become an essential part of daily hygiene routines across European countries, driven by rising awareness of personal grooming, social confidence, and health-conscious lifestyles. Over the years, the market has transitioned...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Global Raloxifene Hydrochloride Market Growing at 5.8% CAGR Driven by Dual Benefits in Bone Health & Cancer PreventionAccording to a new report from Intel Market Research, the global Raloxifene Hydrochloride market was valued at USD 1.05 billion in 2025 and is projected to reach USD 1.75 billion by 2034, growing at a steady CAGR of 5.8% during the forecast period (2026-2034). This growth is fueled by increasing osteoporosis prevalence among aging populations, expanding applications in breast cancer prevention,...0 Commentaires 0 Parts 43 Vue 0 Aperçu